Pharmacological Aspects of (-)-Deprenyl
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2017-2031
Author(s):
K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2463-2475
Author(s):
Pal Pacher and Valeria Kecskemeti
Silencing of Disease-related Genes by Small Interfering RNAs
Journal:
Current Molecular Medicine
Volume:
4
Page:
507-517
Author(s):
U. Fuchs, C. Damm-Welk and A. Borkhardt
Posttranslational Modifications of Tau - Role in Human Tauopathies and Modeling in Transgenic Animals
Journal:
Current Drug Targets
Volume:
5
Page:
503-515
Author(s):
Feng Chen, Della David, Alessandra Ferrari and Jurgen Gotz
Metal and Inflammatory Targets for Alzheimers Disease
Journal:
Current Drug Targets
Volume:
5
Page:
535-551
Author(s):
Jack T. Rogers and Debomoy K. Lahiri
Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimers Disease
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
281-285
Author(s):
Gemma Casadesus, Xiongwei Zhu, Craig S. Atwood, Kate M. Webber, George Perry, Richard L. Bowen and Mark A. Smith
Mitochondria as Therapeutic Targets of Estrogen Action in the Central Nervous System
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
297-313
Author(s):
Jon Nilsen and Roberta Diaz Brinton
Neuroprotective Strategies for Parkinsons Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
309-322
Author(s):
Ippolita Cantuti-Castelvetri and David G. Standaert
Possible Neuroprotective Strategies in ALS
Journal:
Current Neuropharmacology
Volume:
2
Page:
323-329
Author(s):
Simone Beretta, Laura Brighina and Carlo Ferrarese
Possible Neuroprotective Strategies for Huntingtons Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
331-342
Author(s):
James G. Greene